NovoTar Biotech OÜ

Active Registry code 11349409 OÜ Tartu linn Registered 2 Mar 2007
Compare

NovoTar Biotech OÜ is a OÜ based in Tartu linn, registry code 11349409, status: active. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q3 2026 was €0 with employees.

Turnover
0 €
State taxes
—
Labour taxes
—
Employees
—

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2025 91 464 €
    industry median 0 € · companies in the industry: 1 073
  • Net profit margin · 2025 8.3 %
    industry median 13.5 % · companies in the industry: 597

Taxes and turnover

Q4 2023 – Q3 2026
Turnover, € Q3 2026: 0 € · industry median 14 442 € · above 2% of the industry
020 00040 00060 00080 000100 000Q4 2023 Company: 0 € Industry median: 15 375 €Q4·23Q1 2024 Company: 0 € Industry median: 14 938 €Q2 2024 Company: 0 € Industry median: 14 999 €Q2·24Q3 2024 Company: 0 € Industry median: 11 985 €Q4 2024 Company: 0 € Industry median: 16 752 €Q4·24Q1 2025 Company: 0 € Industry median: 15 203 €Q2 2025 Company: 91 464 € Industry median: 14 420 €Q2·25Q3 2025 Company: 0 € Industry median: 13 763 €Q4 2025 Company: 0 € Industry median: 13 976 €Q4·25Q1 2026 Company: 0 € Industry median: 14 268 €Q2 2026 Company: 0 € Industry median: 14 545 €Q2·26Q3 2026 Company: 0 € Industry median: 14 442 €Q3·26020 00040 00060 00080 000100 000Q4 2024 Company: 0 € Industry median: 16 752 €Q1 2025 Company: 0 € Industry median: 15 203 €Q1·25Q2 2025 Company: 91 464 € Industry median: 14 420 €Q3 2025 Company: 0 € Industry median: 13 763 €Q3·25Q4 2025 Company: 0 € Industry median: 13 976 €Q1 2026 Company: 0 € Industry median: 14 268 €Q1·26Q2 2026 Company: 0 € Industry median: 14 545 €Q3 2026 Company: 0 € Industry median: 14 442 €Q3·26
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

State taxes, € Q2 2025: 20 122 €
05 00010 00015 00020 00025 000Q4 2023 Company: —Q4·23Q1 2024 Company: —Q2 2024 Company: —Q2·24Q3 2024 Company: —Q4 2024 Company: —Q4·24Q1 2025 Company: —Q2 2025 Company: 20 122 €Q2·25Q3 2025 Company: —Q4 2025 Company: —Q4·25Q1 2026 Company: —Q2 2026 Company: —Q2·26Q3 2026 Company: —Q3·2605 00010 00015 00020 00025 000Q4 2024 Company: —Q1 2025 Company: —Q1·25Q2 2025 Company: 20 122 €Q3 2025 Company: —Q3·25Q4 2025 Company: —Q1 2026 Company: —Q1·26Q2 2026 Company: —Q3 2026 Company: —Q3·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 — — — —
Q2 2026 — — — —
Q1 2026 — — — —
Q4 2025 — — — —
Q3 2025 — — — —
Q2 2025 91 464 20 122 — —
Q1 2025 — — — —
Q4 2024 — — — —
Q3 2024 — — — —
Q2 2024 — — — —
Q1 2024 — — — —
Q4 2023 — — — —
Q3 2023 — — — —
Q2 2023 82 400 — — —
Q1 2023 — — — —
Q4 2022 — — — —
Q3 2022 — — — —
Q2 2022 — — — —
Q1 2022 80 010 12 000 — —

Financials by year

2016 – 2025
Revenue, € thousand 2025: 91 464 € · industry median 0 € · above 90% of the industry
0501001502002502016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 150 630 € Industry median: 0 €20192020 Company: 222 650 € Industry median: 150 €20202021 Company: 241 325 € Industry median: 0 €20212022 Company: 57 900 € Industry median: 103 €20222023 Company: 0 € Industry median: 76 €20232024 Company: — Industry median: 0 €20242025 Company: 91 464 € Industry median: 0 €20250501001502002502018 Company: — Industry median: —2019 Company: 150 630 € Industry median: 0 €20192020 Company: 222 650 € Industry median: 150 €2021 Company: 241 325 € Industry median: 0 €20212022 Company: 57 900 € Industry median: 103 €2023 Company: 0 € Industry median: 76 €20232024 Company: — Industry median: 0 €2025 Company: 91 464 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 7 625 € · +5 019.4% vs 2024 · industry median 0 € · above 79% of the industry
-20 000020 00040 00060 00080 0002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 14 031 € Industry median: 3 €20192020 Company: 65 821 € Industry median: 28 €20202021 Company: 22 202 € Industry median: 1 €20212022 Company: 1 996 € Industry median: 0 €20222023 Company: -4 618 € Industry median: 0 €20232024 Company: -155 € Industry median: 0 €20242025 Company: 7 625 € Industry median: 0 €2025-20 000020 00040 00060 00080 0002018 Company: — Industry median: —2019 Company: 14 031 € Industry median: 3 €20192020 Company: 65 821 € Industry median: 28 €2021 Company: 22 202 € Industry median: 1 €20212022 Company: 1 996 € Industry median: 0 €2023 Company: -4 618 € Industry median: 0 €20232024 Company: -155 € Industry median: 0 €2025 Company: 7 625 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 8.3 % · industry median 13.5 % · above 44% of the industry
01020302016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 9.3 % Industry median: 12.7 %20192020 Company: 29.6 % Industry median: 23.8 %20202021 Company: 9.2 % Industry median: 25.1 %20212022 Company: 3.4 % Industry median: 17.7 %20222023 Company: — Industry median: 16.8 %20232024 Company: — Industry median: 15.8 %20242025 Company: 8.3 % Industry median: 13.5 %202501020302018 Company: — Industry median: —2019 Company: 9.3 % Industry median: 12.7 %20192020 Company: 29.6 % Industry median: 23.8 %2021 Company: 9.2 % Industry median: 25.1 %20212022 Company: 3.4 % Industry median: 17.7 %2023 Company: — Industry median: 16.8 %20232024 Company: — Industry median: 15.8 %2025 Company: 8.3 % Industry median: 13.5 %2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2025: 108 826 € · +7.5% vs 2024
0501001502016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 61 694 €20192020 Company: 126 776 €20202021 Company: 104 398 €20212022 Company: 105 974 €20222023 Company: 101 356 €20232024 Company: 101 201 €20242025 Company: 108 826 €20250501001502018 Company: —2019 Company: 61 694 €20192020 Company: 126 776 €2021 Company: 104 398 €20212022 Company: 105 974 €2023 Company: 101 356 €20232024 Company: 101 201 €2025 Company: 108 826 €2025
Equity, € thousand 2025: 108 821 € · +7.5% vs 2024
0501001502016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 60 950 €20192020 Company: 126 771 €20202021 Company: 103 973 €20212022 Company: 105 969 €20222023 Company: 101 351 €20232024 Company: 101 196 €20242025 Company: 108 821 €20250501001502018 Company: —2019 Company: 60 950 €20192020 Company: 126 771 €2021 Company: 103 973 €20212022 Company: 105 969 €2023 Company: 101 351 €20232024 Company: 101 196 €2025 Company: 108 821 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.51.01.52.02016 Company: 0 Industry median: —20162017 Company: 0 Industry median: —20172018 Company: 0 Industry median: 120182019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 120202021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250.00.51.01.52.02018 Company: 0 Industry median: 12019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 12021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 22023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Assets, € Equity, € Employees
2025 91 464 7 625 108 826 108 821 0
2024 — -155 101 201 101 196 0
2023 0 -4 618 101 356 101 351 0
2022 57 900 1 996 105 974 105 969 0
2021 241 325 22 202 104 398 103 973 0
2020 222 650 65 821 126 776 126 771 0
2019 150 630 14 031 61 694 60 950 0
2018 — — — — 0
2017 — — — — 0
2016 — — — — 0
2015 — — — — 0
2014 — — — — 0
2013 — — — — 0
2012 — — — — 0
2011 — — — — 0
2010 — — — — 0
2009 — — — — 0
2008 — — — — 0
2007 — — — — 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
8.3 %
Net profit / revenue
Return on equity (ROE)
7.0 %
Net profit / equity
Return on assets (ROA)
7.0 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets
Debt ratio
0.0 %
Liabilities / assets
Current ratio
21 765.20
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 11 Jun 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 26 May 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 2 May 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 21 Apr 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 24 Apr 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 14 May 2021 Company’s own e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 18 Oct 2020 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 72101Research and experimental development on natural sciences and engineering Main
Rulings
Number, date Title Deadline State Document
Ä 20037974 / 10
9 Oct 2026
Amendment under Code of Civil Procedure § 595¹ (1) In force
9 Oct 2026
PDF
Ä 20037974 / 9
1 Sep 2023
Amendment entry In force
1 Sep 2023
PDF
Ä 20037974 / 8
18 Jan 2018
Amendment entry In force
18 Jan 2018
PDF
Ä 20037974 / 7
22 Dec 2017
Amendment entry In force
22 Dec 2017
PDF
Ä 20037974 / 6
4 Dec 2017
Amendment entry In force
4 Dec 2017
PDF
Ä 20037974 / 5
10 May 2017
Amendment entry In force
10 May 2017
PDF
Ä 20037974 / 4
16 Mar 2012
Amendment entry In force
16 Mar 2012
PDF
Ä 20037974 / M2
28 Feb 2012
Ruling to eliminate deficiencies In force
28 Feb 2012
PDF
Ä 20037974 / M1
16 Dec 2011
Ruling to eliminate deficiencies In force
16 Dec 2011
PDF
Ä 20037974 / 3
11 Jun 2010
Amendment entry In force
11 Jun 2010
PDF
Ä 37974 / 2
7 Dec 2007
Amendment entry In force
7 Dec 2007
PDF
Ä 37974
1 Mar 2007
First entry In force
2 Mar 2007
PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data